Watching and learning: how cancer screenings affect people with fanconi anemia

NCT ID NCT06744283

Recruiting now Knowledge-focused Sponsor: National Cancer Institute (NCI) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 27 times

Summary

This study looks at anxiety related to cancer screenings in adults with Fanconi anemia, a rare condition that raises cancer risk. Researchers will observe 20 participants during their regular screening visits, noting body language, worries, and the clinic environment. No treatments or changes to care are involved—the goal is simply to understand the experience better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors and clinics better support people with Fanconi anemia during cancer screenings, potentially reducing anxiety.
What could go wrong: This is a very small observational study (20 people) that only watches and takes notes. It won't test any treatment, so it cannot directly change care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FANCONI ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fanconi anemia neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FANCONI ANEMIA

Contacts and locations

Locations

National Cancer Institute (NCI)
RECRUITING

Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.